G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 4 (4), 129-38
- https://doi.org/10.4254/wjh.v4.i4.129
Abstract
The metabolic syndrome, one of the most common clinical conditions in recent times, represents a combination of cardiometabolic risk determinants, including central obesity, glucose intolerance, insulin resistance, dyslipidemia, non-alcoholic fatty liver disease and hypertension. Prevalence of the metabolic syndrome is rapidly increasing worldwide as a consequence of common overnutrition and consequent obesity. Although a unifying picture of the pathomechanism is still missing, the key role of the pre-receptor glucocorticoid activation has emerged recently. Local glucocorticoid activation is catalyzed by a triad composed of glucose-6-phosphate-transporter, hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum. The elements of this system can be found in various cell types, including adipocytes and hepatocytes. While the contribution of glucocorticoid activation in adipose tissue to the pathomechanism of the metabolic syndrome has been well established, the relative importance of the hepatic process is less understood. This review summarizes the available data on the role of the hepatic triad and its role in the metabolic syndrome, by confronting experimental findings with clinical observationsKeywords
This publication has 83 references indexed in Scilit:
- Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic HumansDiabetes, 2009
- Maintenance of luminal NADPH in the endoplasmic reticulum promotes the survival of human neutrophil granulocytesFEBS Letters, 2008
- Deletion of Hexose-6-phosphate Dehydrogenase Activates the Unfolded Protein Response Pathway and Induces Skeletal MyopathyPublished by Elsevier BV ,2008
- Hexose-6-phosphate Dehydrogenase Modulates 11β-Hydroxysteroid Dehydrogenase Type 1-Dependent Metabolism of 7-keto- and 7β-hydroxy-neurosteroidsPLOS ONE, 2007
- Silencing of the human microsomal glucose‐6‐phosphate translocase induces glioma cell death: Potential new anticancer target for curcuminFEBS Letters, 2006
- Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase is based on a common pyridine nucleotide pool in the lumen of the endoplasmic reticulumMolecular and Cellular Endocrinology, 2006
- Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductaseFEBS Letters, 2004
- Altered Control of Cortisol Secretion in Adult Men with Low Birth Weight and Cardiovascular Risk FactorsJournal of Clinical Endocrinology & Metabolism, 2001
- Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patternsJournal of Endocrinology, 1994
- Influence of thyroid function on the in vivo cortisol ⇌ cortisone equilibrium in manJournal of Steroid Biochemistry, 1983